mach1_8k.htm
SECURITIES
AND EXCHANGE COMMISSION
|
Washington
D.C., 20549
|
Form
8-K
Current
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of Report (Date of Earliest Event Reported): August 12,
2009
Mach
One Corporation
|
(Exact
Name of Registrant as Specified in its
Charter)
|
Commission
File Number: 333-146744
Nevada
|
88-0338837
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(I.R.S.
Employer
Identification
No.)
|
974
Silver Beach Road
Belgium,
WI 53004
|
(Address
of Principal Executive Offices, Including Zip
Code)
|
888-400-7179
|
(Registrant's
Telephone Number, Including Area
Code)
|
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act(17CFR240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act(17CFR240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act(17CFR240.13e-4(c))
|
Section
5 — Corporate Governance and Management
Item
5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Resignation
of a Principal Officer and a Board Member
On August
12, 2009, Dennis Severson advised the Registrant of his resignation as a
Director from the Registrant’s Board of Directors. The Board of
Directors accepted Mr. Severson’s resignation and thanked him for his past
services to the Registrant. .Mr. Severson’s decision to resign did not arise or
result from any disagreement with the Registrant on any matter relating to the
Registrant’s operations, policies or practices. Mr. Severson had been a director
of the Registrant since June, 2008.
On August
31, 2009, Monte B. Tobin, by unanimous vote of the Directors to engage a new
CEO, advised the Registrant of his resignation from the positions of President,
Chief Executive Officer and Secretary of the Registrant. Mr. Tobin remains
Chairman of the Board of Directors. Mr. Tobin’s decision to resign did not arise
or result from any disagreement with the Registrant on any matter relating to
the Registrant’s operations, policies or practices. Mr. Tobin had been the
President, Chief Executive Officer and Secretary of the Registrant since its
organization in August, 2004.
Appointment
of Principal Officers
On
September 1, 2009, the Board of Directors of the Registrant appointed Tad M.
Ballantyne to serve as the Acting Chief Executive Officer of the Registrant
pending the final negotiations with the person to assume the position of Chief
Executive Officer. Mr. Ballantyne has been a director of the Registrant since
January, 2009 and his full resume is set forth in the Registrant’s Form 10-K for
its year ended December 31, 2008 and filed with the SEC on April 15, 2009, which
is incorporated herein by reference.
On
September 1, 2009, the Board of Directors appointed Steve Grubner to serve as
Acting President of the Registrant pending the final negotiations with the new
CEO and Chief Operating Officer of the Registrant. Mr. Grubner’s
résumé is as follows:
Steve
Grubner is a rare senior manager who can excel across a broad spectrum of
functional business areas. Prior to his position with Mach One Corporation, Mr.
Grubner was CFO for GeneThera, a publicly traded biotech company. During his
tenure with GeneThera, Mr. Grubner was responsible for all SEC financial
reporting, provided executive management, and executed public and private
capital campaigns.
Mr.
Grubner has also had a substantial career in the technology business where he
held numerous senior management positions in sales, finance and operations
negotiating corporate transactions and alliances with multi-national companies
that are household names. Mr. Grubner holds a J.D. from John Marshall Law School
and a B.A. in economics from the University of Michigan.
On
September 1, 2009, the Board of Directors of the Registrant appointed Patrick G.
Sheridan to serve as Secretary of the Registrant. Mr. Sheridan has
been the Chief Financial Officer of the Registrant since March, 2009, and his
full resume is set forth in the Registrant’s Form 8-K which was filed with the
SEC on March 13, 2009, and which is incorporated herein by
reference.
Section
7 — Regulation FD
Item
7.01 Regulation FD Disclosure.
A press
release regarding the appointment of Mr. Ballantyne as Acting Chief Executive
Officer and Mr. Grubner as Interim President and Chief Operating Officer was
published on November 6, 2009, and is attached to this Form 8-K as Exhibit 99.
Item
9.01. Financial Statements and Exhibits
|
99.1
|
Press
Release dated November 5, 2009.
|
Signature(s)
Pursuant
to the Requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the Undersigned hereunto
duly authorized.
|
Mach
One Corporation
|
|
|
|
|
|
|
|
|
Date:
November 6, 2009
|
By:
|
Tad M. Ballantyne
Interim CEO
|
|
|
|
|
|
Mach
One Announces Appointment of Interim Chief Executive Officer and Chief Operating
Officer
BELGIUM,
Wis., November 6, 2009 /PRNewswire-FirstCall via COMTEX/ — Mach One
Corporation (OTCBB: MNCN), announced today that its Board of Directors has
appointed Tad M. Ballantyne to serve as the Company’s Interim Chief Executive
Officer and Steve Grubner to serve as the Company’s Interim President and Chief
Operating Officer effective September 1, 2009.
About
Mach One Corporation:
Mach One
Corporation ( www.machonecorp.com )
is a global wellness company that provides biotechnology based solutions to help
address one of the world’s most pressing and costly needs — positive, long-term
health and longevity benefits for humans and disease-threatened animals of
commercial operations. While animal wellness, organic and sustainable products
are our initial primary focus, we intend in the near future to add
Nutraceuticals to our growing list of operating groups. As an ongoing objective
we intend to be agile and swift in spotting business opportunities and
respective businesses to expand our vision for positive contribution to global
wellness.
Cautionary
Statement: This news release may include certain “Forward-looking statements”
within the meaning of Section 21E of the United States Securities Exchange Act,
as amended. All statements, other than statements of historical fact, included
in this release are forward-looking statements that involve various risks and
uncertainties. There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ materially from those
anticipated in such statements. This notice expressly qualifies all
forward-looking statements in this release.
SOURCE
Mach One Corporation
URL:
http://www.machonecorp.com